BAYERCROPBSEBayer CropScience LtdHighNeutral
Announced Tue, 26 May · 17:21 IST

Pursuant to Regulation 30 and 33 of the SEBI LODR Regulations, 2015, we are pleased to furnish the Audited Financial Results of the Company along with the Audit Report for the financial ....

Pat Growth 25pctResults View source PDF

BAYERCROP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹4530.00
prior close
₹4605.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+0.7+0.4+0.4+0.4-0.3-1.5-3.2-2.8-5.6-5.7-10.1-6.3
Up moveDown movePending
AI summary

Bayer CropScience Limited reported audited financial results for FY26 ending March 31, 2026. Revenue from operations grew to ₹56,750 million from ₹54,734 million in FY25, a modest increase of approximately 3.7%. Profit after tax increased significantly by 21.3% to ₹6,892 million compared to ₹5,680 million in the previous year. Total comprehensive income stood at ₹6,771 million. Earnings per share improved from ₹126.38 to ₹153.35. The statutory auditor Deloitte Haskins & Sells LLP issued an unmodified (clean) opinion, confirming the financial statements give a true and fair view. The Board also recommended a final dividend of ₹60 per share. Operating cash flow remained strong at ₹10,785 million during the year.

Likely market impact

The 21% PAT growth outpacing revenue growth indicates improved operational efficiency and cost management. The clean audit opinion with no going concern issues is positive for investor confidence. Strong cash generation supports the dividend payout.